AstraZeneca
highlights congress highlights at and in met primary with safety and tolerability profile in studies show across all known variants including | AstraZeneca
Company
Deck Type
Deck date
April 2023
Slide
22 of 41
Related slides by other companies
Results
September 2023
Other recent decks by AstraZeneca
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io